BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16079519)

  • 1. Release from or through a wax matrix system. VI. Analysis and prediction of the entire release process of the wax matrix tablet.
    Yonezawa Y; Ishida S; Sunada H
    Chem Pharm Bull (Tokyo); 2005 Aug; 53(8):915-8. PubMed ID: 16079519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release from or through a wax matrix system. V. Applicability of the square-root time law equation for release from a wax matrix tablet.
    Yonezawa Y; Ishida S; Sunada H
    Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):904-8. PubMed ID: 12913226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release from or through a wax matrix system. I. Basic release properties of the wax matrix system.
    Yonezawa Y; Ishida S; Sunada H
    Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1448-51. PubMed ID: 11724236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release from or through a wax matrix system. III. Basic properties of release through the wax matrix layer.
    Yonezawa Y; Ishida S; Suzuki S; Sunada H
    Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):814-7. PubMed ID: 12045337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release from or through a wax matrix system. IV. Generalized expression of the release process for a reservoir device tablet.
    Yonezawa Y; Ishida S; Suzuki S; Sunada H
    Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1219-22. PubMed ID: 12237539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release from or through a wax matrix system. II. Basic properties of release from or through the wax matrix layer.
    Yonezawa Y; Ishida S; Suzuki S; Sunada H
    Chem Pharm Bull (Tokyo); 2002 Feb; 50(2):220-4. PubMed ID: 11848213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of internal structure on kinetics of drug release from wax matrix tablets.
    Ishino R; Yoshino H; Hirikawa Y; Noda K
    Chem Pharm Bull (Tokyo); 1990 Dec; 38(12):3440-5. PubMed ID: 2092942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cogrinding time on the release of pentoxifylline from waxy matrix tablets.
    Otsuka M; Matsuda Y
    J Pharm Sci; 1994 Jul; 83(7):956-61. PubMed ID: 7965674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained release phenylpropanolamine hydrochloride from ATO 888 matrix.
    Perez MA; Ghaly ES; Marti A
    P R Health Sci J; 1993 Dec; 12(4):263-7. PubMed ID: 8140204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmable drug release of highly water-soluble pentoxifylline from dry-coated wax matrix tablets.
    Otsuka M; Matsuda Y
    J Pharm Sci; 1995 Apr; 84(4):443-7. PubMed ID: 7629734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-unit dosage formulations of theophylline for controlled release applications.
    Uhumwangho MU; Okor RS
    Acta Pol Pharm; 2007; 64(6):553-9. PubMed ID: 18323251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-Layered Matrix of Shellac Wax-Lutrol in Controlled Dual Drug Release.
    Phaechamud T; Choncheewa CE
    AAPS PharmSciTech; 2016 Dec; 17(6):1326-1335. PubMed ID: 26694059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of drug release from an acrylic polymer-wax matrix tablet.
    Huang HP; Mehta SC; Radebaugh GW; Fawzi MB
    J Pharm Sci; 1994 Jun; 83(6):795-7. PubMed ID: 9120808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of powder blend and tablet structure on drug release mechanisms of hydrophobic starch acetate matrix tablets.
    van Veen B; Pajander J; Zuurman K; Lappalainen R; Poso A; Frijlink HW; Ketolainen J
    Eur J Pharm Biopharm; 2005 Oct; 61(3):149-57. PubMed ID: 16005196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of processing methods and heat treatment on the formation of wax matrix tablets for sustained drug release.
    Zhang YE; Tchao R; Schwartz JB
    Pharm Dev Technol; 2001; 6(2):131-44. PubMed ID: 11416986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mathematical model considering change of diffusion coefficient for predicting dissolution behavior of acetaminophen from wax matrix dosage form.
    Nitanai Y; Agata Y; Iwao Y; Itai S
    Int J Pharm; 2012 May; 428(1-2):82-90. PubMed ID: 22405986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the compressibility of wax matrix granules of acetaminophen and their admixtures with various tableting bases.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2006 Apr; 19(2):103-7. PubMed ID: 16751119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of drug release from acetaminophen granules by melt granulation technique - consideration of release kinetics.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2006 Jan; 19(1):22-7. PubMed ID: 16632448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets.
    Maboos M; Yousuf RI; Shoaib MH; Nasiri I; Hussain T; Ahmed HF; Iffat W
    Lipids Health Dis; 2018 Jun; 17(1):136. PubMed ID: 29885655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.